Home
About
Overview
Sharing Data
ORCID
Help
History (47)
A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD.
What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis.
Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis.
When Should Therapy for Inflammatory Bowel Disease Be Stopped?
See All 47 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
When Should Therapy for Inflammatory Bowel Disease Be Stopped?
When Should Therapy for Inflammatory Bowel Disease Be Stopped? Gastroenterol Hepatol (N Y). 2015 Jun; 11(6):400-2.
View in:
PubMed
authors with profiles
David Rubin